Gustaaf van Imhoff

Gustaaf van Imhoff is a researcher at the University Medical Center Groningen, part of the University of Groningen, affiliated with the Department of Hematology. His work focuses on hematological malignancies including Hodgkin lymphoma, non-Hodgkin lymphoma, and stem cell transplantation outcomes. Dr. van Imhoff has co-supervised PhD students Wouter Plattel and A. Diepstra. His research contributes to UN Sustainable Development Goals related to good health and well-being (SDG 3).

Key research interests include lymphoma treatment protocols, long-term mortality analysis in cancer patients, and diagnostic biomarkers. He leads clinical trials evaluating therapies like rituximab and alemtuzumab, with recent studies focusing on Burkitt lymphoma and T-cell lymphoma in elderly populations. His work bridges clinical practice and translational research, emphasizing evidence-based oncology.

Collaborations span European institutions through networks like HOVON/SAKK and DSHNHL. His publications address chemotherapy efficacy, graft-versus-host disease prevention, and imaging techniques for treatment response evaluation. Despite no listed awards, his high-impact studies (e.g., Lancet Haematology, Journal of the National Cancer Institute) reflect significant contributions to hematology.